Intermed Labs Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 9 Months
- Last Filing with ROC 31 Mar 2021
- Revenue Growth %
- Profit Growth 14.46%
- Ebitda
- Net Worth
- Total Assets 6.96%
About Intermed Labs
Intermed Labs Private Limited (ILPL) is a Private Limited Indian Non-Government Company incorporated in India on 25 May 2018 (Six years and nine months 3 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Paresh Kirtilal and Geeta Mehta serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74900MH2018PTC309965
- Company No.
309965
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 May 2018
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Intermed Labs?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Paresh Kirtilal  | Director | 25-May-2018 | Current |
| Geeta Mehta | Director | 15-Mar-2021 | Current |
Financial Performance of Intermed Labs.
Intermed Labs Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 14.46% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Intermed Labs?
In 2021, Intermed Labs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Intermed Life Sciences Private LimitedParesh Kirtilal is a mutual person
- Intermed Laboratories Private Limited
Paresh Kirtilal is a mutual person
- Kinshuk Developers Private Limited
Paresh Kirtilal and Geeta Mehta are mutual person
- Kuvam Realties Private Limited
Paresh Kirtilal and Geeta Mehta are mutual person
- Father Worldwide Private Limited
Paresh Kirtilal is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Intermed Labs?
Unlock and access historical data on people associated with Intermed Labs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Intermed Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Intermed Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
